|
Getting Help > Clinical Trials > Illinois
A Multi-Center, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase II Study of 2 Oral Dose Groups of AZD7325, with a Lorazepam Arm, in Subjects with Generalized Anxiety Disorder (GAD)
Alexian Brothers Center for Psychiatric Research, Hoffman Estates
Principal Investigator: Mark Lerman, MD
Description of Study: Feeling closed in by anxiety? If excessive worry and anxiety are overwhelming your life, consider participating in this clinical research study evaluating an investigational medication for generalized anxiety disorder (GAD). The purpose of this research study is to determine the safety and effectiveness of an investigational medication for treating GAD. If you are one of the millions of people struggling with GAD, you know how this condition can put a significant strain on your daily life. Unfortunately, current GAD treatments can often cause undesirable side effects and may take several weeks to reduce anxiety.
The investigational medication being evaluated in this research study comes in the form of an oral tablet. Previous research with the investigational medication has shown that it is well tolerated by patients, with no serious side effects reported to date. As a participant in this research study, you may also receive oral lorazepam capsules, which have already been approved by the FDA for the treatment of anxiety.
Eligibility Criteria: To pre-qualify for this research study, you must:
- Be 18-65 years of age
- Be exhibiting symptoms of
generalized anxiety disorder
(GAD), such as chronic anxiety
and excessive worry
- Not have a history of
schizophrenia, bipolar disorder, or
eating disorders
- Not have a history of
substance abuse
Both non-smokers and smokers who
meet participation requirements are
eligible for this research study.
Qualified participants will receive research study medication as well as research study related medical evaluations at no cost.
Reimbursement for time and travel may
also be provided.
Contact: Phil Carona, (847) 230-3591
Location: Alexian Brothers Center for Psychiatric Research, 1786 Moon Lake Blvd, Suite 200, Hoffman Estates, IL 60169
Website: www.abbhh.org/research
|
